Steven Cohen’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.4K Hold
1,000
– – ﹤0.01% 3781
2026
Q2
$37.2K Buy
+1,000
New +$32.3K ﹤0.01% 3826

Other funds holding CLDX

Steven Cohen's CLDX Position: Q3 2026 in Review

Steven Cohen reduced its Celldex Therapeutics (CLDX) stake by 44% in Q3 2026, selling an estimated $1.98M and leaving 65,405 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2381.

Steven Cohen first reported a position in CLDX in Q1 2021 and has held it in 18 quarters since. The position peaked at $109M in Q4 2023. 249 funds tracked by Wall St. Rank hold CLDX as of Q3 2026.

  • Steven Cohen held 65,405 shares of Celldex Therapeutics worth $2.12M as of Q3 2026.
  • Steven Cohen sold 51,812 Celldex Therapeutics shares in Q3 2026, an estimated $1.98M.
  • Celldex Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2381 holding.
  • Steven Cohen first reported a position in Celldex Therapeutics in Q1 2021 and has held it in 18 quarters since.
  • Steven Cohen's Celldex Therapeutics position peaked at $109M in Q4 2023.
  • 249 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.